In sum, the activation of TLR2, TLR4, TLR7, TLR9 and NLRP3 are almost certainly maintained by DAMPs in severe COVID-19, ALI/ARDS and sepsis and may need to be therapeutically addressed [217,218,226]. This evidence concerns the gene TLR4 and acute respiratory distress syndrome.